According to a recent Form 13F filing submitted to the SEC, Retirement Systems of Alabama disclosed a noteworthy new position in Omnicell, Inc. (NASDAQ: OMCL) stock. Here’s what you need to know about Omnicell, Inc., as well as Retirement Systems of Alabama’s position in shares of OMCL stock:
Retirement Systems of Alabama
The Retirement Systems of Alabama inlcudes the Teachers Retirement System, Employees Retirement System, Judicial Retirement Fund, and other pension and benefit funds in Alabama, with over $21 billion in managed 13F securities. The Retirement Systems of Alabama serves the interests of its members by preserving the excellent benefits and soundness of the systems at the least expense to the state of Alabama and all Alabama taxpayers. You can learn more about Retirement Systems of Alabama on their website here.
Retirement Systems of Alabama’s New Position in OMCL Stock
According to the most recent 13F filing from Retirement Systems of Alabama, the institutional investment manager added a meaningful position in Omnicell, Inc. (NASDAQ: OMCL), with 57,983 shares, which represents approximately 0.1299% of the 44,649,801 total OMCL shares outstanding. Based on OMCL’s last closing price of $55.85 per share, Retirement Systems of Alabama’s stake in OMCL is worth approximately $3,238,350.55, assuming no change in the position size. If you’re not very familiar with Omnicell, Inc., learn more below.
Omnicell, Inc. (NASDAQ: OMCL)
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility’s in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Be sure to check out more recent 13F filings here to stay up to date on the latest disclosures from institutional investment managers like Retirement Systems of Alabama. Also be sure to check out more recent 13F filing analysis news here.